(3829027), M. S., (22443761), H. A., (22136905), H. M. Y., (11644294), A. M. S., (22443762), U. I., (18607830), M. A., . . . (20545181), A. S. (2025). Repurposing Nirmatrelvir for Hepatocellular Carcinoma: Network Pharmacology and Molecular Dynamics Simulations Identify HDAC3 as a Key Molecular Target.
Chicago Style (17th ed.) Citation(3829027), Muhammad Suleman, et al. Repurposing Nirmatrelvir for Hepatocellular Carcinoma: Network Pharmacology and Molecular Dynamics Simulations Identify HDAC3 as a Key Molecular Target. 2025.
MLA (9th ed.) Citation(3829027), Muhammad Suleman, et al. Repurposing Nirmatrelvir for Hepatocellular Carcinoma: Network Pharmacology and Molecular Dynamics Simulations Identify HDAC3 as a Key Molecular Target. 2025.
Warning: These citations may not always be 100% accurate.